Wondering if Stryker at around US$312.20 is offering value or just pricing in high expectations already? This article breaks down what the current share price might be implying. The stock is up 2.1% o
Stryker (NYSE:SYK) reported that an early-2026 cyber incident disrupted parts of its operations but did not derail overall demand. The company highlighted record Mako robotics installations and broade
Stryker faces cyberattack fallout, but strong procedure demand, record Mako adoption and global expansion continue to support long-term growth.
Prestige Consumer Healthcare (PBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MDT is betting on ablation, robotics and hypertension therapies as next growth drivers, but tariffs, FX and pricing pressures cloud near-term upside.
ABT's Exact Sciences acquisition expands its cancer diagnostics portfolio as new data and screening guidelines strengthen growth prospects.
MDT trades at about 14x forward earnings with a 3.5% yield as fiscal 2027 guidance points to steady growth, but margins face tariffs and mix pressure.
Stryker (NYSE:SYK) has introduced its Pangea Plating System trauma platform to the European market. The launch marks an extension of a product line that was previously available in North America. The
View interactive chart, options flow, and AI analysis for SYK on Zorveq Finance.
Open SYK Chart & Analysis →